Stocklytics Platform
Asset logo for symbol PDSB
PDS Biotechnology
Penny Stock
Asset logo for symbol PDSB



Income Statement (PDSB)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
gross Profit-$14.40K-$14.40K-$14.40K-$74.66K-$74.36K
NET Income-$10.60M-$10.89M-$10.84M-$11.53M-$9.65M
total Revenue$0.00$0.00$0.00$0.00$0.00

Balance Sheet (PDSB)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt-$42.52M-$32.70M-$30.64M-$37.10M-$41.69M
stockholders Equity$37.18M$26.13M$24.48M$32.44M$41.01M
total Assets$69.00M$59.39M$57.18M$63.75M$68.44M
total Debt$24.10M$23.85M$23.60M$23.51M$23.50M
total Liabilities$31.82M$33.25M$32.70M$31.31M$27.43M

Cash Flow (PDSB)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow$20.01M$10.76M$802.32K$240.00K$4.56M
free Cash Flow-$9.93M-$8.45M-$7.17M-$4.81M-$13.18M
investing Cash Flow-----
operating Cash Flow-$9.93M-$8.45M-$7.17M-$4.81M-$13.18M

PDS Biotechnology (PDSB) Financials

PDS Biotechnology Corp (PDSB) is a biotech company that focuses on the development of novel therapies for various types of cancer. The company's income statement shows its financial performance over a specific period of time. It provides information about the company's revenue, expenses, and net income. For instance, the gross profit reflects the amount of revenue that exceeds the cost of goods sold. This metric indicates the efficiency of the company's operations and its ability to generate profits from its products or services.

EBIT and EBITDA are profitability measures that analyze the company's operating performance. EBIT, or earnings before interest and taxes, indicates the company's profitability before considering interest and tax expenses. EBITDA, or earnings before interest, taxes, depreciation, and amortization, further removes the impact of non-cash expenses from the equation. These metrics provide insight into the company's ability to generate profit from its core operations. It also helps investors and analysts evaluate the company's financial health and compare it to its competitors.

The net income from stockholders represents the profit or loss attributable to the company's shareholders. It is calculated by subtracting all expenses, including interest and taxes, from the company's total revenue. This metric is crucial for investors as it indicates the company's profitability and its ability to provide a return on investment to its shareholders.

The balance sheet reveals the company's financial position at a specific point in time. It includes information about the company's assets, liabilities, and stockholders' equity. Total assets represent the value of all the resources owned by the company, including cash, investments, and property. Total liabilities represent the company's debts and obligations. Stockholders' equity shows the amount of money that shareholders have contributed to the company and the retained earnings. It reflects the net worth of the company.

Cash equivalents on the balance sheet represent highly liquid and short-term investments that are easily convertible to cash. These investments provide the company with quick access to funds and can be used to meet its short-term obligations. Net debt is calculated by subtracting the company's cash and cash equivalents from its total debt. It indicates the company's overall debt position and its ability to repay its debts. Higher net debt may indicate higher financial risk.

The total revenue represents the income generated by the company from its products or services. It is a key indicator of the company's growth and success in the market. The cash flow statement provides information about the company's cash inflows and outflows during a specific period. It includes operating cash flow, investing cash flow, and financing cash flow. Operating cash flow represents the cash generated from the company's core operations, while investing cash flow represents the cash used for investments in assets or acquisitions. Financing cash flow includes the cash flow from issuing or repurchasing equity and debt.

Free cash flow is the cash generated by the company after accounting for its capital expenditures. It indicates the amount of money the company has available for various purposes, such as paying dividends, reducing debt, or investing in growth opportunities. Investors often consider free cash flow as a key metric to assess the financial health and sustainability of a company's operations.

add PDS Biotechnology to watchlist

Keep an eye on PDS Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level